You searched for Antibody candidate - Page 36 of 69

News and Trends 17 Jan 2017

This Herpes Cure is Proving to Work Better than its Predecessors

…completed a Phase II trial in which its candidate pritelivir outperformed the current standard care for genital herpes. When compared to the antiviral drug valacyclovir, the candidate reduced virus shedding,…

January 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Apr 2025

The biotech job market in 2025: Still in survival mode?

…of remote biotech jobs. During the pandemic and in its immediate aftermath, remote roles helped decentralize the job market. But that trend has sharply reversed. Employers are now favoring candidates…

April 9, 2025 - 7 minutesmins - By Jules Adam

Best in Biotech 12 Nov 2024

Six exosome therapy companies driving development in the field

…diseases, such as cancer, neurological, and inflammatory diseases, several exosome therapy companies have come to the fore in recent times, with many just beginning to advance their candidates through the…

November 12, 2024 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 19 Dec 2023

Nine biotech companies to watch in 2024

…noteworthy entry into the clinical-stage biopharmaceutical sector. At the heart of Aiolos Bio’s mission is AIO-001, a humanized anti-TSLP monoclonal antibody, developed as a treatment for moderate-to-severe asthma. This antibody…

December 19, 2023 - 12 minutesmins - By Jules Adam

geneva biotech serono university of geneva

Best in Biotech 30 May 2017

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

…Before its IPO, it attracted big-time investors like Medicxi and Sofinnova Partners, some of the top European biotech investors. The biotech has 3 different candidates at the clinical stage for…

May 30, 2017 - 7 minutesmins - By Denise Neves Gameiro

News and Trends 8 Dec 2016

Meet the Newest ALS Pioneer Company from Switzerland

…drug candidates using cost-effective clinical strategies. If everything goes as planned, Chorus will step in in 2018, when the first human study of AL-S’ candidate is projected to begin. The…

December 8, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Mar 2023

Candidate found to inhibit malignant melanoma growth

Malignant melanoma is a relatively aggressive type of skin cancer. When detected early, it is usually treatable by surgical resection only, but metastases develop, often spreading to distant areas. Currently,…

March 31, 2023 - 2 minutesmins - By Jim Cornall

In Depth 4 Mar 2024

ALS: how close are we to a cure?

…of neuroinflammation, and inhibits it. In phase 1 and 2 trials, the candidate was evaluated in 250 people, and was found to be safe and well-tolerated. Another candidate, pridopidine, is…

March 4, 2024 - 9 minutesmins - By Roohi Mariam Peter

Screenshot 2016 10 18 at 5.42.27 PM e1476805403921

News and Trends 18 Oct 2016

This New Biotech wants to Regrow Neurons to cure Parkinson’s

Mavalon Therapeutics will develop a drug candidate for Parkinson’s that can stop the disease progression by activating the growth of dying neurons. Mavalon Therapeutics, born today in the UK, will…

October 18, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 16 Apr 2025

HIV innovation: Six companies developing new treatments in 2025

…technology to target and remove latent viral DNA embedded within the host genome. Its lead candidate, EBT-101, employs an adeno-associated virus (AAV) delivery system to introduce CRISPR-Cas9 along with dual…

April 16, 2025 - 9 minutesmins - By Jules Adam

News and Trends 31 Mar 2023

Ablaze Pharmaceuticals to develop first-in-class therapy for liver cancer in China

…has been collaborating with Ablaze on an investigator-initiated trial of a radiopharmaceutical drug candidate targeted on PSMA. I am very glad to learn this novel candidate targeted on GPC3 by…

March 31, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 29 Aug 2024

Eight biotech companies you should know about in Spain

…the development of antibody drug conjugates (ADCs) to attack advanced cancer. The company currently has its focus on two programs. Its lead candidate is ONA-255, which is an undisclosed first-in-class…

August 29, 2024 - 11 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

This Herpes Cure is Proving to Work Better than its Predecessors

The biotech job market in 2025: Still in survival mode?

Six exosome therapy companies driving development in the field

Nine biotech companies to watch in 2024

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

Meet the Newest ALS Pioneer Company from Switzerland

Candidate found to inhibit malignant melanoma growth

ALS: how close are we to a cure?

This New Biotech wants to Regrow Neurons to cure Parkinson’s

HIV innovation: Six companies developing new treatments in 2025

Ablaze Pharmaceuticals to develop first-in-class therapy for liver cancer in China

Eight biotech companies you should know about in Spain

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!